Application Note: The Development of HPV Vaccines and the Contributions of Luminex xMAP® Technology
11 October 2021
The 4vHPV and 9vHPV vaccines provide additional protection against types of HPV responsible for other diseases, including genital warts along with vulvar, vaginal, and anal cancers. xMAP multiplexing technology, especially the cLIA and total IgG LIA assays, has facilitated the development and clinical testing of these vaccines in a high-throughput and robust manner. Download this white paper to find out the true power of xMAP technology.